Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
RESEARCH TOOLSreports
BSEM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.77 - $28.26
Previous CloseN/A
Volume47.30K
Average Volume (3M)68.58K
Market Cap
$231.43M
Enterprise ValueN/A
Total Cash (Recent Filing)$14.61M
Total Debt (Recent Filing)$4.48M
Price to Earnings (P/E)9.6
Beta1.97
Next Earnings
Aug 26, 2025EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.27
Shares Outstanding16,338,436
10 Day Avg. Volume70,152
30 Day Avg. Volume68,575
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)6.53
Price to Sales (P/S)0.00
P/FCF Ratio10.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioStem Technologies News
PremiumCompany Announcements
BioStem Technologies Reports Record Revenue and Profitability
PremiumCompany Announcements
BioStem Technologies Reports Strong Q1 2025 GrowthPremiumCompany Announcements
BioStem Technologies Reports Record Revenue in Earnings Call
PremiumCompany Announcements
BioStem Technologies Reports Record Revenue Growth in 2024
PremiumPre-Earnings
Is BSEM a Buy, Before Earnings?
PremiumCompany Announcements
BioStem Technologies Achieves Record Revenue Growth in Q3 2024
BSEM FAQ
What was BioStem Technologies Inc’s price range in the past 12 months?
BioStem Technologies Inc lowest stock price was $6.77 and its highest was $28.26 in the past 12 months.
What is BioStem Technologies Inc’s market cap?
BioStem Technologies Inc’s market cap is $231.43M.
When is BioStem Technologies Inc’s upcoming earnings report date?
BioStem Technologies Inc’s upcoming earnings report date is Aug 26, 2025 which is in 77 days.
How were BioStem Technologies Inc’s earnings last quarter?
BioStem Technologies Inc released its earnings results on May 12, 2025. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of N/A by $0.27.
Is BioStem Technologies Inc overvalued?
According to Wall Street analysts BioStem Technologies Inc’s price is currently Overvalued.
Does BioStem Technologies Inc pay dividends?
BioStem Technologies Inc does not currently pay dividends.
What is BioStem Technologies Inc’s EPS estimate?
BioStem Technologies Inc’s EPS estimate is 0.32.
How many shares outstanding does BioStem Technologies Inc have?
BioStem Technologies Inc has 16,338,436 shares outstanding.
What happened to BioStem Technologies Inc’s price movement after its last earnings report?
BioStem Technologies Inc reported an EPS of $0.27 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -16.908%.
Which hedge fund is a major shareholder of BioStem Technologies Inc?
Currently, no hedge funds are holding shares in BSEM
BioStem Technologies Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BSEM Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
92.72%
12-Months-Change
Fundamentals
Return on Equity
122.26%
Trailing 12-Months
Asset Growth
226.91%
Trailing 12-Months
Company Description
BioStem Technologies Inc
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
BSEM Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and profitability achievements for BioStem Technologies, underscoring the company's operational strength and financial resilience. Despite challenges such as increased operating expenses and market uncertainty due to LCD delays, the company remains on a positive trajectory with ongoing clinical trials and strategic initiatives. The sentiment is bolstered by strong cash reserves and gross profit margins, although the pending SEC review for NASDAQ uplisting presents a potential hurdle.Read More>